A detailed history of Pure Financial Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 10,879 shares of RXST stock, worth $93,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,879
Previous 10,859 0.18%
Holding current value
$93,450
Previous $141,000 31.21%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$6.65 - $13.14 $133 - $262
20 Added 0.18%
10,879 $97,000
Q2 2025

Jul 18, 2025

BUY
$13.0 - $26.12 $650 - $1,306
50 Added 0.46%
10,859 $141,000
Q1 2025

Apr 23, 2025

SELL
$24.37 - $35.84 $87,805 - $129,131
-3,603 Reduced 25.0%
10,809 $272,000
Q2 2024

Jul 18, 2024

SELL
$50.42 - $64.29 $200,671 - $255,874
-3,980 Reduced 21.64%
14,412 $867,000
Q1 2024

Apr 16, 2024

BUY
$35.51 - $57.92 $653,099 - $1.07 Million
18,392 New
18,392 $948,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $237M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.